CITY SUNSCREEN SERUM BROAD SPECTRUM SPF 30 SUPERGOOP- homosalate, octisalate, avobenzene, octocrylene cream 
Baxter Laboratories Pty. Ltd.

----------

City Sunscreen Serum Broad Spectrum SPF 30

Active ingredients: Purpose

Homosalate 8%, Octisalate 4%, Avobenzene 3%, Octocrylene 2% Sunscreen

Purpose

Uses Simultaneously protects skin, combats premature aging and moisturizes on contact

helps prevent sunburn

If used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging skin aging caused by the sun

Keep out of reach of children

Warnings

For external use only.

Do not use on damaged or broken skin

When using this product, keep out of of eyes.

Rinse with water to remove.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions: Apply liberally 15 minutes before sun exposure

Use a water resistant sunscreen if swimming or sweating

Reapply at least every 2 hours

children under 6 months: ask a doctor

Sun Protection Measures: Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreenwith Broad Spectrum SPF value of 15 or higher and other sun protection measures including:

Limit time in the sun,especially from 10 a.m. -2p.m.

Wear long-sleeved shirts, pants, hats, and sunglasses

Inactive Ingredients Purified water (Aqua), Cyclometicone, Isostearyl Neopentanoate, Glycerin, Ceteareth-20, Polypropylene, Cetearyl Alcohol, Xanthan Gum, d-Panthenol, Octanohydroxamic acid, Caprylyl Glycol, Silica, Triacontanyl PVP, Cetyl Dimethicone, Ammonium Acryloyldimethyltaurate/VP Copolymer, PEG-40 Stearate, Tocopheryl, Disodium EDTA, Pentylene Glycol, Pantheyl Triacetate, Sodium Lactate, Lactic Acid, Serine, Urea, Sorbitol, Sodium Chloride, Allantoin, Oleyl Alcohol, Ethyl Linoleate.

City Sunscreen

SERUM

With Vitamins E & B5

Supergoop!

Front

Back

Box

Packette


CITY SUNSCREEN SERUM BROAD SPECTRUM SPF 30  SUPERGOOP
homosalate, octisalate, avobenzene, octocrylene cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70157-002
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE8 g  in 100 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE4 g  in 100 mL
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE3 g  in 100 mL
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
CYCLOMETHICONE (UNII: NMQ347994Z)  
GLYCERIN (UNII: PDC6A3C0OX)  
XANTHAN GUM (UNII: TTV12P4NEE)  
PANTHENOL (UNII: WV9CM0O67Z)  
CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
POLYOXYL 40 STEARATE (UNII: 13A4J4NH9I)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
PENTYLENE GLYCOL (UNII: 50C1307PZG)  
SODIUM LACTATE (UNII: TU7HW0W0QT)  
LACTIC ACID (UNII: 33X04XA5AT)  
SERINE (UNII: 452VLY9402)  
UREA (UNII: 8W8T17847W)  
SORBITOL (UNII: 506T60A25R)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
ALLANTOIN (UNII: 344S277G0Z)  
OLEYL ALCOHOL (UNII: 172F2WN8DV)  
ETHYL LINOLEATE (UNII: MJ2YTT4J8M)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70157-002-0150 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product12/07/2010
2NDC:70157-002-0220 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product12/07/2010
3NDC:70157-002-0310 mL in 1 TUBE; Type 0: Not a Combination Product12/07/2010
4NDC:70157-002-0460 mL in 1 TUBE; Type 0: Not a Combination Product12/07/2010
5NDC:70157-002-053 mL in 1 PACKET; Type 0: Not a Combination Product12/07/2010
6NDC:70157-002-0615 mL in 1 TUBE; Type 0: Not a Combination Product07/19/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02012/07/2010
Labeler - Baxter Laboratories Pty. Ltd. (740537709)

Revised: 10/2024
Document Id: 24c841ad-5d6f-5a1a-e063-6394a90abcbf
Set id: a29e5a69-d17e-45ef-8dde-e99c6e4a2b22
Version: 7
Effective Time: 20241018
 
Baxter Laboratories Pty. Ltd.